Drug Database
L01XG01 bortezomib
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Bortezomib 1mg powder for solution for injection
- POM Bortezomib 2.5mg powder for solution for injection
- POM Bortezomib 2.5mg/ml Solution for Injection (3.5mg total content)
- POM Bortezomib 3.5 mg powder for solution for injection
- POM Bortezomib 3.5 mg powder for solution for injection
- POM Bortezomib 3.5mg powder for solution for injection
- POM Bortezomib 3.5mg powder for solution for injection
- POM Bortezomib 3.5mg powder for solution for injection
- POM Bortezomib Accord 2.5 mg/mL solution for injection
- POM Bortezomib Dr. Reddys 3.5 mg Powder For Solution For Injection
- POM Bortezomib Hospira 2.5 mg powder for solution for injection
- POM Bortezomib Hospira 3.5 mg powder for solution for injection
- POM Bortezomib Milpharm 3.5 mg powder for solution for injection
- POM Bortezomib Sandoz 3.5 mg Powder for solution for injection
- POM Bortezomib SUN 3.5 mg powder for solution for injection
- POM Bortezomib Zentiva 3.5 mg powder for solution for injection
- POM Velcade 3.5mg powder for solution for injection (Great Britain)
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).